(469) 625-1000

info@medrocs.com

8901 Virginia Pkwy

Ste 200, Mckinney, TX 75071

M-F: 9am-6pm

Sat: 10am - 1pm

Paxlovid COVID-19 Blister Pack

Paxlovid now available at Medrocs Pharmacy

Paxlovid is now available at Medrocs Pharmacy in Mckinney TX. Paxlovid is available by prescription only and should be initiated as soon as possible after diagnosis of COVID-19 and within five days of symptom onset. Contact Medrocs Pharmacy today to know more about the drug availability and price

Paxlovid COVID-19 Blister Pack

Paxlovid is the latest COVID-19 treatment that’s been all over the news. The drug was granted an emergency use authorization (EUA) by the Food and Drug Administration (FDA) in December, 2021 for anyone ages 12 and older who weighs at least 88 pounds, and is at high risk for severe disease. 

Paxlovid is an oral antiviral pill that can be taken at home to help keep high-risk patients from getting so sick that they need to be hospitalized. So, if you test positive for the coronavirus and a health care provider writes you a prescription, you can take pills at home and lower your risk of going to the hospital. You can also get Paxlovid directly from your pharmacist, provided you can give the pharmacist your electronic or printed medical records, including a list of medications you are already taking, and blood test results from the last 12 months. 

Paxlovid is an antiviral therapy meant to treat mild to moderate COVID-19, Dr. Michelle Hormozian, a clinical coordinator and pharmacist with the University of Southern California School of Pharmacy, told McClatchy News. It consists of two different oral antivirals: nirmatrelvir and ritonavir.

  • Nirmatrelvir: is actually a COVID protease inhibitor, and what that means is it basically prevents viral replication of COVID,” Hormozian said
  • Nitonavir: works by blocking the body’s metabolism of the first drug so that the patient can maintain sufficient levels of nirmatrelvir to work properly, Hormozian said.

Pfizer’s Covid pill remains 89% effective in final analysis, company says. Paxlovid, Pfizer’s pill to treat Covid-19, retained its 89% efficacy at preventing hospitalization and death in the full results of a study of 2,246 high-risk patients, the company said Tuesday. Checkout full report here

You have to take Paxlovid within five days of developing symptoms.

Like all antivirals, Paxlovid works best early in the course of an illness—in this case, within the first five days of symptom onset, says Jeffrey Topal, MD, a Yale Medicine infectious diseases specialist who is involved in determining COVID-19 treatment protocols for Yale New Haven Hospital patients.

“Once you’ve been ill with the virus for more than a week, the damage done to the body in a severe case can’t be undone by the antiviral,” he says.

Pills are packaged in a “dose card,” basically a medication blister pack that allows you to punch out the pills as needed.

Adults:

  • Dose pack 300 mg nirmatrelvir and 100 mg ritonavir: Each daily blister card contains 4 nirmatrelvir tablets (150-mg) and 2 ritonavir tablets (100-mg)
  • Dose pack 150 mg nirmatrelvir and 100 mg ritonavir: Each daily blister card contains 2 nirmatrelvir tablets (150-mg) and 2 ritonavir tablets (100-mg)

     

December 22, 2021: Emergency use authorization issued for treatment of mild-to-moderate coronavirus disease 2019 (COVID-19) in adults and pediatric patients (aged ≥12 years and weight ≥40 kg) testing positive for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus, and who are at high risk for progression to severe COVID-19, including hospitalization or death

<12 years: Safety and efficacy not established

300 mg nirmatrelvir plus 100 mg ritonavir PO BID x 5 days

Initiate as soon as possible after COVID-19 diagnosis and within 5 days of symptom onset

Completing the full 5-day treatment course and isolate in accordance with public health recommendations are important to maximize viral clearance and minimize viral transmission

If patient is hospitalized due to severe or critical COVID-19 after starting treatment with nirmatrelvir/ritonavir, completion of the full 5-day treatment is at the healthcare provider’s discretion

 

 

Possible side effects of Paxlovid include dysgeusia (altered or impaired sense of taste), diarrhea,
increased blood pressure, and myalgia (muscle aches). Allergic reactions, abdominal pain, nausea, and
malaise (feeling generally unwell) have also been reported after Paxlovid use.

Possible side effects of Paxlovid include dysgeusia (altered or impaired sense of taste), diarrhea,
increased blood pressure, and myalgia (muscle aches). Allergic reactions, abdominal pain, nausea, and
malaise (feeling generally unwell) have also been reported after Paxlovid use.

Paxlovid is available as a prescription drug among participating pharmacies

Paxlovid has many drug interactions. The list below only includes some of the possible interactions. It’s important to discuss your current medications with your pharmacist before starting Paxlovid. That way, they can let you know if any changes need to be made or if Paxlovid isn’t safe for you to take.

Some Paxlovid interactions include:

  • Alpha blockers, such as tamsulosin (Flomax)

  • Antipsychotics, such as lurasidone (Latuda)

  • Blood thinners, such as rivaroxaban (Xarelto) and warfarin (Coumadin, Jantoven)

  • Certain antiplatelet medications, such as clopidogrel (Plavix)

  • Certain HIV medications

  • Certain seizure medications, such as carbamazepine (Tegretol)

  • Erectile dysfunction medications, such as sildenafil (Viagra)

  • Heart rhythm medications, such as amiodarone (Pacerone)

  • Hormonal birth control

  • Opioid pain medications, such as hydrocodone and oxycodone

  • St. John’s wort, an OTC dietary supplement

  • Statin cholesterol medications, such as simvastatin (Zocor)

coronavirus COVID-19

COVID 19 Updates

Coronavirus (COVID-19) Update: FDA Authorizes Pharmacists to Prescribe Paxlovid with Certain Limitations

U.S. Food and Drug Administration revised the Emergency Use Authorization (EUA) for Paxlovid (nirmatrelvir and ritonavir), to authorize state-licensed pharmacists to prescribe Paxlovid to eligible patients, with certain limitations to ensure appropriate patient assessment and prescribing of Paxlovid. Source

coronavirus COVID-19

Why Not Everyone Should Take Paxlovid

Paxlovid is not meant for everyone. Only those who are at increased risk for severe disease from COVID-19 qualify for the drug, including people over age 12 who have weakened immune systems or other health conditions that increase risk of serious effects of COVID-19—like asthma, cancer, liver disease, lung disease, heart disease, and obesity. Click here to read full article

RSS Other Health Updates